Intermediate versus short-course hormone therapy and mortality in men with high-risk prostate cancer treated with radiation therapy

被引：0
|
作者：
Nanda, Akash
Chen, Ming-Hui
Moran, Brian Joseph
Braccioforte, Michelle H.
D'Amico, Anthony Victor
机构：
[1] MD Anderson Canc Ctr Orlando, Orlando, FL USA
[2] Univ Connecticut, Storrs, CT USA
[3] Prostate Canc Fdn Chicago, Westmont, IL USA
[4] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.83
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
83
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prostate Cancer-Specific Mortality and the Extent of Therapy in Healthy Elderly Men With High-Risk Prostate Cancer
    Hoffman, Karen E.
    Chen, Ming-Hui
    Moran, Brian J.
    Braccioforte, Michelle H.
    Dosoretz, Daniel
    Salenius, Sharon
    Katin, Michael J.
    Ross, Rudi
    D'Amico, Anthony V.
    CANCER, 2010, 116 (11) : 2590 - 2595
  • [32] PI-RADS score is associated with biochemical control and distant metastasis in men with intermediate-risk and high-risk prostate cancer treated with radiation therapy
    Turchan, William Tyler
    Kauffmann, Greg
    Patel, Pritesh
    Oto, Aytek
    Liauw, Stanley L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (06) : 600.e1 - 600.e8
  • [33] Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer
    Montorsi, Francesco
    Mazzone, Elio
    Gandaglia, Giorgio
    Stabile, Armando
    Salonia, Andrea
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2022, 208 (01): : 223 - 224
  • [34] The outcome of intermediate risk prostate cancer treated with escalated dose radiation with or without neoadjuvant hormone therapy
    Perry, D. J.
    McGee, L.
    Essenmacher, L. M.
    Bolton, S.
    Ager, J.
    Forman, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S332 - S333
  • [35] Radiotherapy and hormone therapy in patients with high-risk prostate cancer
    Nature Clinical Practice Urology, 2008, 5 (1): : 4 - 4
  • [36] Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy
    Karlsdottir, Asa
    Muren, Ludvig Paul
    Wentzel-Larsen, Tore
    Johannessen, Dag C.
    Haukaas, Svein Andreas
    Halvorsen, Ole Johan
    Dahl, Olav
    ACTA ONCOLOGICA, 2009, 48 (06) : 874 - 881
  • [37] Radiotherapy and hormone therapy in patients with high-risk prostate cancer
    Nature Clinical Practice Oncology, 2008, 5 (1): : 8 - 8
  • [38] Duration of Short-Course Androgen Suppression Therapy and the Risk of Death As a Result of Prostate Cancer
    D'Amico, Anthony V.
    Chen, Ming-Hui
    Crook, Juanita
    Armstrong, John G.
    Malone, Shawn
    Steigler, Allison
    Dunne, Mary
    Kantoff, Philip W.
    Denham, James W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (35) : 4682 - 4687
  • [39] Cost-Effectiveness of Primary Radiation Therapy Versus Radical Prostatectomy for Intermediate-to High-Risk Prostate Cancer
    Dorth, Jennifer A.
    Lee, W. Robert
    Chino, Junzo
    Abouassaly, Robert
    Ellis, Rodney J.
    Myers, Evan R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (02): : 383 - 390
  • [40] Short-course preoperative radiation therapy for operable rectal cancer
    Tankel, K
    Hay, J
    Ma, R
    Toy, E
    Larsson, S
    MacFarlane, J
    AMERICAN JOURNAL OF SURGERY, 2002, 183 (05): : 509 - 511
12345